# Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

> **NCT06293261** · — · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 5047 (actual)

## Conditions studied

- Hypertension
- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg

## Key facts

- **NCT ID:** NCT06293261
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-27
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 5047 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06293261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06293261, "Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06293261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*